Viewing Study NCT03632759


Ignite Creation Date: 2025-12-24 @ 2:34 PM
Ignite Modification Date: 2026-01-07 @ 7:45 AM
Study NCT ID: NCT03632759
Status: COMPLETED
Last Update Posted: 2022-01-24
First Post: 2018-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
Sponsor: Carla Greenbaum, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module